Amundi’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769M Sell
1,591,888
-288,942
-15% -$76.7M 0.19% 91
2026
Q1
$206M Buy
1,880,830
+823,477
+78% +$117M 0.06% 272
2025
Q4
$176M Sell
1,057,353
-363,910
-26% -$60.9M 0.05% 351
2025
Q3
$314M Buy
1,421,263
+1,319,643
+1,299% +$217M 0.1% 180
2025
Q2
$9M Sell
101,620
-277,140
-73% -$21.9M ﹤0.01% 838
2025
Q1
$21.1M Sell
378,760
-130,752
-26% -$12.1M 0.01% 698
2024
Q4
$66.6M Buy
509,512
+509,481
+1,643,487% +$47.8M 0.02% 505
2024
Q3
$1.64K Buy
+31
New +$1.46K ﹤0.01% 1955

Other funds holding ALAB

Amundi's ALAB Position: Q2 2026 in Review

Amundi reduced its Astera Labs (ALAB) stake by 15% in Q2 2026, selling an estimated $76.7M and leaving 1,591,888 shares worth $769M. The position accounts for 0.19% of the portfolio, ranked #91.

Amundi first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Amundi held 1,591,888 shares of Astera Labs worth $769M as of Q2 2026.
  • Amundi sold 288,942 Astera Labs shares in Q2 2026, an estimated $76.7M.
  • Astera Labs made up 0.19% of Amundi's portfolio in Q2 2026, its #91 holding.
  • Amundi first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.